We identified target(s) for NTS/NTSR signaling in pancreatic cancer cells and also aimed to determine whether NTS/NTSR1 signaling pathways might be potential target(s) for pancreatic cancer treatment in vivo. The gene discussed is NTSR1; the disease is familial pancreatic carcinoma.